Literature DB >> 23336597

Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.

Wei Gao1, Yuzhu Bian, Thomas M S Chang.   

Abstract

Poly(ethylene glycol)-Poly(lactic acid) block-copolymer (PEG-PLA) was prepared and characterized using Fourier transform infrared spectrophotometer (FTIR). Glutaraldehyde was used to crosslink stroma-free hemoglobin (SFHb), superoxide dismutase (SOD), catalase (CAT), and carbonic anhydrase (CA) into a soluble complex of PolySFHb-SOD-CAT-CA. PEG-PLA was then used to nanoencapsulated PolySFHb-SOD-CAT-CA by oil in water emulsification. This resulted in the formation of PLA-PEG-PolySFHb-SOD-CAT-CA nanocapsules that have enhanced antioxidant activity and that can transport both O2 and CO2. These are homogeneous particles with an average diameter of 100 nm with good dispersion and core shell structure, high entrapment efficiency (EE%), and nanocapsule percent recovery. A lethal hemorrhagic shock model in rats was used to evaluate the therapeutic effect of the PLA-PEG-PolySFHb-SOD-CAT-CA nanocapsules. Infusion of this preparation resulted in the lowering of the elevated tissue PCO2 and also recovery of the mean arterial pressure (MAP).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23336597      PMCID: PMC3725180          DOI: 10.3109/21691401.2012.751180

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  26 in total

1.  SEMIPERMEABLE MICROCAPSULES.

Authors:  T M CHANG
Journal:  Science       Date:  1964-10-23       Impact factor: 47.728

Review 2.  Therapeutic applications of polymeric artificial cells.

Authors:  Thomas Ming Swi Chang
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

Review 3.  50th anniversary of artificial cells: their role in biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy and nanorobotics.

Authors:  Thomas Ming Swi Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2007

4.  Cationic amylose-encapsulated bovine hemoglobin as a nanosized oxygen carrier.

Authors:  Wei Gao; Baoyong Sha; Wei Zou; Xuan Liang; Xiangzhong Meng; Hao Xu; Jun Tang; Daocheng Wu; Lixian Xu; Hui Zhang
Journal:  Biomaterials       Date:  2011-09-01       Impact factor: 12.479

Review 5.  Polymeric nanoparticles for hemoglobin-based oxygen carriers.

Authors:  Anna Maria Piras; Alberto Dessy; Federica Chiellini; Emo Chiellini; Claudio Farina; Massimiliano Ramelli; Elena Della Valle
Journal:  Biochim Biophys Acta       Date:  2008-04-11

6.  Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report.

Authors:  W P Yu; T M Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  1994

7.  HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.

Authors:  Jonathan S Jahr; Colin Mackenzie; L Bruce Pearce; Arkadiy Pitman; A Gerson Greenburg
Journal:  J Trauma       Date:  2008-06

8.  Polynitroxyl hemoglobin: a pharmacokinetic study of covalently bound nitroxides to hemoglobin platforms.

Authors:  Paul W Buehler; Chad R Haney; Anil Gulati; Li Ma; Carleton J C Hsia
Journal:  Free Radic Biol Med       Date:  2004-07-01       Impact factor: 7.376

9.  Inhaled nitric oxide enables artificial blood transfusion without hypertension.

Authors:  Binglan Yu; Michael J Raher; Gian Paolo Volpato; Kenneth D Bloch; Fumito Ichinose; Warren M Zapol
Journal:  Circulation       Date:  2008-04-07       Impact factor: 29.690

10.  Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.

Authors:  F D'Agnillo; T M Chang
Journal:  Nat Biotechnol       Date:  1998-07       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.